Skip to content

Percutaneous Pinning vs Orthosis and Early Mobilization

A Randomized Comparison Between Percutaneous Pinning and Non-surgical Management of Proximal Phalangeal Fractures

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04561661
Acronym
POEM
Enrollment
60
Registered
2020-09-23
Start date
2021-03-03
Completion date
2026-12-31
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Injuries, Finger Fracture

Brief summary

This study aims at investigating if splinting and early mobilization is a better method, regarding range of motion, for treating fractures of the base phalanx of the fingers compared to surgery with pinning. This will be achieved through a randomised clinical trial comparing the two methods.

Detailed description

Proximal phalangeal fractures of the hand are very common and affect patients of all ages. . Most fractures heal without complications but these injuries can result in impaired hand function and prolonged inability to work and perform activities of daily living. If there is a dislocation that cannot easily be repositioned to a stable position, surgery might be required. Surgery is often performed with percutaneous pinning and immobilisation in plaster for 4 weeks. Good results of non-surgical treatment with a splint that allows immediate mobilization of the interphalangeal joints has been reported. This study will compare these two methods for treating fractures of the base phalanx of the fingers. Recruited patients will be randomized to one of the two treatment arms: 1. surgery with pinning 2. conservative treatment with a splint. Primary outcome is total active range of motion in the affected finger at 3, 6 months and 1 , 3 years. Secondary outcomes are number of sick days and various patient related outcome measures.

Interventions

Closed reduction, percutaneous pinning and plaster

PROCEDUREConservative treatment

Closed reduction, custom made orthosis and early mobilization

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Fractures of the base phalanx of digit 2-5 in the hand.

Exclusion criteria

* Fracture older than 2 weeks. * More than 25° of sagittal plane and/or 10° lateral angulation after reposition. * Intra-articular step \>1mm. * Associated fractures in other bones (i e metacarpals, middle and distal phalanges) and/or tendon and nerve injuries in any finger. * Open fractures. * Patient age \<18 years. * Inability to co-operate with the follow-up protocol (i.e. language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).

Design outcomes

Primary

MeasureTime frameDescription
TAM (Total active range of motion)3 monthsTotal active range of motion measured in degrees of the affected finger.

Secondary

MeasureTime frameDescription
Number of sick days3 monthsNumber of sick days from the intervention until full return to work.
Patient related outcome measure DASH3, 6 months and 1 and 3 yearsDisability of the Arm, Shoulder and Hand score (DASH). 0 points means no disability and 100 maximum disability.
Grips strength3, 6 months and 1 and 3 yearsMeasured in kilograms (JAMAR)
Patient related outcome measure EQ-5D3, 6 months and 1 and 3 yearsEuroQols quality of life index. Consists of an index based on the questionnaire where 0 means death and 1 means full quality of life and one visual analog scale 0-100 where patients rate their health from bad (0) to excellent (100).
Patient related outcome measure HQ-83, 6 months and 1 and 3 yearsHQ-8 is a questionnaire specifically for hand injuries. Each question gives a score 0-100, where 0 means no problems and 100 means worst imaginable problem.
Patient related outcome measure HADS3, 6 months and 1 and 3 yearsHospital Anxiety and Depression Scale (HADS). The score is consists of one depression scale from 0 to 21, where 0 is no signs of depression and one anxiety scale from 0 to 21, where 0 means no anxiety.

Countries

Sweden

Contacts

Primary ContactHenrik Alfort, MD
henrik.alfort@ki.se+46704044648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026